-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UJtpUYq4lJcUrvXe7xNYc6hfRYDwoGH64aKwNBuP63UFPoIJ2upsE136VlvWTt2R MeUTrFrvRbRABQJgES6QZw== 0001181431-07-072854.txt : 20071203 0001181431-07-072854.hdr.sgml : 20071203 20071203212402 ACCESSION NUMBER: 0001181431-07-072854 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071128 FILED AS OF DATE: 20071203 DATE AS OF CHANGE: 20071203 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Abraxis Biosciences, Inc. CENTRAL INDEX KEY: 0001409012 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300431735 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11755 WILSHIRE BLVD., 20TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: 310-883-1300 MAIL ADDRESS: STREET 1: 11755 WILSHIRE BLVD., 20TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: New Abraxis, Inc. DATE OF NAME CHANGE: 20070806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CALHOUN KIRK K CENTRAL INDEX KEY: 0001203721 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33657 FILM NUMBER: 071281956 BUSINESS ADDRESS: STREET 1: 11777 SAN VICENTE BLVD STREET 2: STE 530 CITY: WEST LOS ANGELES STATE: CA ZIP: 90024 BUSINESS PHONE: 3104704222 4 1 rrd180401.xml FORM 4 X0202 4 2007-11-28 0 0001409012 Abraxis Biosciences, Inc. ABII 0001203721 CALHOUN KIRK K C/O ABRAXIS BIOSCIENCE, INC. 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025 1 0 0 0 Nonqualified Stock Option (Right to Purchase) 29.44 2007-11-28 4 A 0 4773 0 A 2007-11-29 2012-10-25 Common Stock 4773 4773 D Nonqualified Stock Option (Right to Purchase) 34.65 2007-11-28 4 A 0 1909 0 A 2007-11-29 2013-04-24 Common Stock 1909 1909 D Nonqualified Stock Option (Right to Purchase) 82.94 2007-11-28 4 A 0 1272 0 A 2007-11-29 2014-12-13 Common Stock 1272 1272 D Nonqualified Stock Option (Right to Purchase) 95.26 2007-11-28 4 A 0 1272 0 A 2007-11-29 2015-06-17 Common Stock 1272 1272 D Nonqualified Stock Option (Right to Purchase) 94.84 2007-11-28 4 A 0 2970 0 A 2007-11-29 2015-07-21 Common Stock 2970 2970 D Nonqualified Stock Option (Right to Purchase) 47.30 2007-11-28 4 A 0 4243 0 A 2007-11-29 2016-08-01 Common Stock 4243 4243 D Nonqualified Stock Option (Right to Purchase) 55.44 2007-11-28 4 A 0 10000 0 A 2008-11-29 2017-11-29 Common Stock 10000 10000 D The Option was issued in connection with the spin-off of issuer's common stock from APP Pharmaceuticals, Inc. (formerly Abraxis BioScience, or "New APP") on November 13, 2007 in exchange for existing New APP options. Under the terms of the employee matters agreement executed between the issuer and New APP, the number of shares and exercise price became calculable on November 28, 2007. The exercise price of this option was determined on the first ten days trading average of the issuer's common stock, which was determinable on November 28, 2007. /s/ Charles Kim, Power of Attorney 2007-12-03 -----END PRIVACY-ENHANCED MESSAGE-----